CD19

Dec 03, 2019

CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications

Nov 15, 2019

Gracell Announces Five Presentations at the Annual Meeting of American Society of Hematology (ASH)

Jun 17, 2019

CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy

Jun 11, 2019

Pediatric CAR T-Cell Immunotherapy Trial Aims to Improve Remission Rates of Leukemia at Children's National Health System

Apr 23, 2019

Gracell Bio Announces FasT CAR-T, a Breakthrough Technology for Hematological Malignancies

Feb 22, 2019

Global CAR T Cell Therapy Market 2017-2028: Market is Expected to Grow with a CAGR of Over 46%

Nov 02, 2018

Autolus Therapeutics to Present New Data at the ASH Annual Meeting

Nov 01, 2018

Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 60th ASH Annual Meeting

Jun 16, 2018

European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia

Jun 12, 2018

Clinical Data Highlighting Single-Cell Polyfunctionality as a Potential Predictor of Patient Response to CAR-T Cell Therapy Published in "Blood"